# Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

> **NCT00005009** · PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 7 (actual)

## Conditions studied

- Kidney Transplant Recipients

## Interventions

- **BIOLOGICAL:** Varivax®

## Key facts

- **NCT ID:** NCT00005009
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-02
- **Primary completion:** 2001-06-16
- **Final completion:** 2001-06-16
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2017-02-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005009, "Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00005009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*